Key statistics
On Wednesday, Genelux Corp (GNLX:NAQ) closed at 2.62, 63.75% above the 52 week low of 1.60 set on Aug 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.57 |
---|---|
High | 2.66 |
Low | 2.54 |
Bid | 2.60 |
Offer | 2.62 |
Previous close | 2.55 |
Average volume | 73.86k |
---|---|
Shares outstanding | 34.54m |
Free float | 28.37m |
P/E (TTM) | -- |
Market cap | 88.07m USD |
EPS (TTM) | -0.9704 USD |
Data delayed at least 15 minutes, as of Oct 09 2024 21:00 BST.
More ▼
Announcements
- Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit
- Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference
- Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates
- Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2024
- Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants
- Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants
- Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates
- Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Genelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancer
- Genelux Corporation Reports Third Quarter 2023 Financial Results and Provides General Business Updates
More ▼